Coya Therapeutics (COYA) Price to Sales (2023 - 2026)

Coya Therapeutics has disclosed Price to Sales across 4 years of filings, most recently posting 563.0 for Q2 2026.

• In Q2 2026, Price to Sales fell 4.21% year-over-year to 563.0; the TTM figure through Jun 2026 stood at 17.11 (down 92.46% YoY), while the FY2025 annual figure was 12.21, down 54.66% from the prior year.
• Price to Sales came in at 563.0 for Q2 2026 at Coya Therapeutics, up from 368.0 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 49043.87 in Q4 2024 to a low of 12.55 in Q4 2023.
• Average Price to Sales over 4 years is 5221.59, with a median of 393.8 recorded in 2025.
• Year-over-year, Price to Sales surged 390758.17% in 2024 and slumped 99.95% in 2025.
• Over 4 years, Price to Sales stood at 12.55 in 2023, then surged by 390758.17% to 49043.87 in 2024, then tumbled by 99.95% to 24.5 in 2025, then surged by 2197.59% to 563.0 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 563.0 in Q2 2026, 368.0 in Q1 2026, and 24.5 in Q4 2025.